KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $332,000 | +12.9% | 97,895 | +24.8% | 0.00% | +33.3% |
| Q2 2018 | $294,000 | -8.1% | 78,411 | 0.0% | 0.00% | -40.0% |
| Q1 2018 | $320,000 | -12.8% | 78,411 | -0.8% | 0.01% | +66.7% |
| Q4 2017 | $367,000 | -22.2% | 79,066 | +18.7% | 0.00% | -40.0% |
| Q3 2017 | $472,000 | -5.2% | 66,594 | -3.5% | 0.01% | -28.6% |
| Q2 2017 | $498,000 | +959.6% | 69,000 | +1087.2% | 0.01% | +600.0% |
| Q4 2015 | $47,000 | -86.5% | 5,812 | -93.5% | 0.00% | -87.5% |
| Q3 2015 | $348,000 | -45.2% | 89,532 | +74.0% | 0.01% | -42.9% |
| Q2 2015 | $635,000 | +2440.0% | 51,446 | +2421.9% | 0.01% | – |
| Q1 2015 | $25,000 | -41.9% | 2,040 | -32.9% | 0.00% | -100.0% |
| Q4 2014 | $43,000 | -55.7% | 3,040 | -55.4% | 0.00% | -50.0% |
| Q3 2014 | $97,000 | -10.2% | 6,815 | -3.2% | 0.00% | 0.0% |
| Q2 2014 | $108,000 | -9.2% | 7,040 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $119,000 | +21.4% | 7,040 | -8.1% | 0.00% | +50.0% |
| Q4 2013 | $98,000 | -71.1% | 7,660 | -77.3% | 0.00% | -75.0% |
| Q3 2013 | $339,000 | +235.6% | 33,700 | +146.9% | 0.01% | +166.7% |
| Q2 2013 | $101,000 | – | 13,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |